Inhibitors | Comment | Organism | Structure |
---|---|---|---|
diisopropyl fluorophosphate | 1 mM, complete inhibition | Homo sapiens | |
pepstatin | 0.3 mM, complete inhibition | Homo sapiens | |
phenylmethylsulfonyl fluoride | 1 mM, complete inhibition | Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.77 | - |
N-benzyloxycarbonyl-Pro-Phe | - |
Homo sapiens | |
1 | - |
angiotensin II | - |
Homo sapiens | |
2 | - |
angiotensin III | - |
Homo sapiens |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
45000 | - |
x * 45000 + x * 66500, SDS-PAGE in presence of 2-mercaptoethanol | Homo sapiens |
66500 | - |
x * 45000 + x * 66500, SDS-PAGE in presence of 2-mercaptoethanol | Homo sapiens |
115000 | - |
gel filtration | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
blood | - |
Homo sapiens | - |
fibroblast | - |
Homo sapiens | - |
kidney | - |
Homo sapiens | - |
lung | - |
Homo sapiens | - |
lymphocyte | - |
Homo sapiens | - |
macrophage | - |
Homo sapiens | - |
polymorphonuclear leukocyte | - |
Homo sapiens | - |
urine | - |
Homo sapiens | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
0.51 | - |
- |
Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
angiotensin II + H2O | about 35% of the activity with angiotensin III | Homo sapiens | ? | - |
? | |
angiotensin III + H2O | - |
Homo sapiens | ? | - |
? | |
N-benzyloxycarbonyl-Pro-Ala + H2O | 33% of the activity with angiotensin III | Homo sapiens | N-benzyloxycarbonyl-Pro + Ala | - |
? | |
N-benzyloxycarbonyl-Pro-Leu + H2O | 12% of the activity with angiotensin III | Homo sapiens | N-benzyloxycarbonyl-Pro + Leu | - |
? | |
N-benzyloxycarbonyl-Pro-Phe + H2O | 8% of the activity with angiotensin III | Homo sapiens | N-benzyloxycarbonyl-Pro + Phe | - |
? | |
N-benzyloxycarbonyl-Pro-Ser + H2O | 7% of the activity with angiotensin III | Homo sapiens | N-benzyloxycarbonyl-Pro + Ser | - |
? | |
N-benzyloxycarbonyl-Pro-Val + H2O | 28% of the activity with angiotensin III | Homo sapiens | N-benzyloxycarbonyl-Pro + Val | - |
? |
Subunits | Comment | Organism |
---|---|---|
? | x * 45000 + x * 66500, SDS-PAGE in presence of 2-mercaptoethanol | Homo sapiens |
Temperature Stability Minimum [°C] | Temperature Stability Maximum [°C] | Comment | Organism |
---|---|---|---|
60 | - |
30 min, 20% loss of activity | Homo sapiens |
70 | - |
15 min, 90% loss of activity | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
4.5 | 5.5 | with N-benzyloxycarbonyl-Pro-Phe, angiotensin II or angiotensin III as substrate | Homo sapiens |
pH Minimum | pH Maximum | Comment | Organism |
---|---|---|---|
4.5 | 7 | - |
Homo sapiens |